As part of their growth strategy, private biotech and pharmaceutical companies often seek to raise capital through initial public offerings (IPOs). In addition to raising capital, an IPO can give a life sciences company a...more
More than ever, life sciences companies are going public to raise capital for future growth. In fact, U.S. equity financing in life sciences skyrocketed to a record $7 billion in 2018—a 69 percent jump over the year...more
2/8/2019
/ Accounting Standards ,
Capital Formation ,
Capital Markets ,
Disclosure Requirements ,
Emerging Growth Companies ,
Initial Public Offering (IPO) ,
Internal Controls ,
Investment Banks ,
Life Sciences ,
Popular ,
Regulatory Standards ,
Reporting Requirements ,
Sarbanes-Oxley ,
Startups ,
Stock Exchange ,
Transparency
The SEC’s rule changes further streamline the pathway for many companies to conduct their initial public offerings and reduce the burdens associated with their subsequent SEC periodic reporting obligations.
On January...more